CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Roberto MorettoDaniele RossiniVeronica ConcaSara LonardiCosimo RasolaCarlotta AntoniottiDaniele SantiniFederica MarmorinoGianluca TomaselloBeatrice BorelliSalvatore CaponnettoGemma ZucchelliAlberto ZaniboniMargherita AmbrosiniAngela BuonadonnaLaura FanchiniSamanta CupiniGianluca MasiAlfredo FalconeChiara CremoliniPublished in: British journal of cancer (2021)
In mCRC with baseline CEA ≥ 10 ng/mL, CEA values can accurately predict PD versus no-PD after the end of the first-line induction therapy.